Prognostic Performance of Multiple Biomarkers in Patients With Non-ST Elevation Acute Coronary Syndrome: Analysis From MERLIN-TIMI 36

Study Questions:

What is the prognostic importance of novel biomarkers [C-terminal provasopressin (copeptin), midregional-pro-adrenomedullin (MR-proADM), and midregional-pro-atrial natriuretic peptide (MR-proANP)] in patients with non-ST-segment elevation (NSTE)-acute coronary syndrome (ACS)?